Inhibition of key enzymes in the inflammatory pathway by hybrid molecules of terpenes and synthetic drugs: In vitro and in silico studies | ||
| dc.conicet.organizacion | Universidad de Talca | |
| dc.conicet.organizacion | Universidad de Talca | |
| dc.conicet.organizacion | Universidad de Talca | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Instituto de Química del Noroeste. Universidad Nacional de Tucumán. Facultad de Bioquímica, Química y Farmacia. Instituto de Química del Noroeste | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Instituto de Química del Noroeste. Universidad Nacional de Tucumán. Facultad de Bioquímica, Química y Farmacia. Instituto de Química del Noroeste | |
| dc.conicet.organizacion | Universidad de Talca | |
| dc.conicet.organizacion | Universidad de Talca | |
| dc.contributor.author | Theoduloz, Cristina | |
| dc.contributor.author | Alzate-Morales, Jans | |
| dc.contributor.author | Jiménez Aspee, Felipe | |
| dc.contributor.author | Isla, Maria Ines | |
| dc.contributor.author | Alberto, Maria Rosa | |
| dc.contributor.author | Pertino, Mariano Walter | |
| dc.contributor.author | Schmeda Hirschmann, Guillermo | |
| dc.date.issued | 2018-10-30 | |
| dc.description.abstract | The aim of this work was to compare the anti-inflammatory activity of compounds prepared from terpenes and the synthetic drugs ibuprofen and naproxen. The anti-inflammatory activity of the hybrid compounds was compared with the activity of the parent compounds. This was accomplished using in vitro inhibition of lipoxygenases (LOX) and COX-2, and in silico docking studies in 15-LOX and COX-2. The synthesized hybrids showed an inhibition of COX-2 and LOX between 9.8%–57.4% and 0.0%–97.7%, respectively. None of the hybrids showed an improvement in the inhibitory effect toward these pro-inflammatory enzymes, compared to the parent terpenes and non-steroidal anti-inflammatory drugs. The docking studies allowed us to predict the potential binding modes of hybrids 6–15 within COX-2 and 15-LOX active sites. The relative affinity of the compounds inside the binding sites could be explained by forming non-covalent interactions with most important and known amino acids reported for those enzymes. A good correlation (r 2 = 0.745) between docking energies and inhibition percentages against COX-2 was found. The high inhibition obtained for compound 10 against COX-2 was explained by hydrogen bond interactions at the enzyme binding site. New synthetic possibilities could be obtained from our in silico models, improving the potency of these hybrid compounds. | es |
| dc.description.fil | Fil: Theoduloz, Cristina. Universidad de Talca; Chile | |
| dc.description.fil | Fil: Alzate-Morales, Jans. Universidad de Talca; Chile | |
| dc.description.fil | Fil: Jiménez-Aspee, Felipe. Universidad de Talca; Chile | |
| dc.description.fil | Fil: Isla, Maria Ines. Universidad Nacional de Tucumán; Argentina. INBIOFIV; Argentina | |
| dc.description.fil | Fil: Alberto, Maria Rosa. Universidad Nacional de Tucumán; Argentina | |
| dc.description.fil | Fil: Pertino, Mariano Walter. Universidad de Talca; Chile | |
| dc.description.fil | Fil: Schmeda-Hirschmann, Guillermo. Universidad de Talca; Chile | |
| dc.format | application/pdf | es |
| dc.identifier.citation | Theoduloz, Cristina; Alzate-Morales, Jans; Jiménez Aspee, Felipe; Isla, Maria Ines; Alberto, Maria Rosa; et al.; Inhibition of key enzymes in the inflammatory pathway by hybrid molecules of terpenes and synthetic drugs: In vitro and in silico studies; Wiley Blackwell Publishing, Inc; Chemical Biology & Drug Design; 93; 3; 30-10-2018; 290-299 | es |
| dc.identifier.institucional | CONICET | |
| dc.identifier.issn | 1747-0277 | es |
| dc.identifier.repo | CONICET Digital | |
| dc.identifier.uri | http://hdl.handle.net/11336/95509 | |
| dc.journal.ciudad | Londres | es |
| dc.journal.number | 3 | es |
| dc.journal.pagination | 290-299 | es |
| dc.journal.pais | Reino Unido | es |
| dc.journal.title | Chemical Biology & Drug Design | es |
| dc.journal.volume | 93 | es |
| dc.language.iso | eng | es |
| dc.publisher | Wiley Blackwell Publishing, Inc | es |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/doi/https://doi.org/10.1111/cbdd.13415 | |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/url/https://onlinelibrary.wiley.com/doi/abs/10.1111/cbdd.13415 | |
| dc.rights | info:eu-repo/semantics/openAccess | * |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.5/ar/ | * |
| dc.subject | ANTI-INFLAMMATORY ACTIVITY | es |
| dc.subject | COMPUTATIONAL ANALYSIS | es |
| dc.subject | COX-2 AND 15-LOX INHIBITION | es |
| dc.subject | IBUPROFEN AND NAPROXEN TERPENYL HYBRIDS | es |
| dc.subject | IN SILICO STUDIES | es |
| dc.subject.classification | Biotecnología relacionada con la Salud | es |
| dc.subject.classification | Biotecnología de la Salud | es |
| dc.subject.classification | CIENCIAS MÉDICAS Y DE LA SALUD | es |
| dc.title | Inhibition of key enzymes in the inflammatory pathway by hybrid molecules of terpenes and synthetic drugs: In vitro and in silico studies | es |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:ar-repo/semantics/artículo | |
| dc.type | info:eu-repo/semantics/publishedVersion | |
Archivos
Bloque original
Cargando...
- Nombre:
- CONICET_Digital_Nro.11e96648-b0e8-4b36-b4bb-1c9ea348ab47_D.pdf
- Tamaño:
- 1.01 MB
- Formato:
- Adobe Portable Document Format